4.5 Article

Reevaluation and Identification of the Best Immunohistochemical Panel (pVHL, Maspin, S100P, IMP-3) for Ductal Adenocarcinoma of the Pancreas

Related references

Note: Only part of the references are listed.
Article Pathology

Diagnostic Value of Immunohistochemical IMP3 Expression in Core Needle Biopsies of Pancreatic Ductal Adenocarcinoma

David Lukas Wachter et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)

Article Pathology

Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens

Hongbing Deng et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)

Article Pathology

New markers of pancreatic cancer identified through differential gene expression analyses: Claudin 18 and annexin A8

Zarir E. Karanjawala et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)

Article Gastroenterology & Hepatology

Immunostaining as an Adjunct to Cytology for Diagnosis of Pancreatic Adenocarcinoma

Banke Agarwal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Mucin expression profile in pancreatic cancer and the precursor lesions

Kohji Nagata et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2007)

Article Oncology

The claudin gene family: expression in normal and neoplastic tissues

Kyle J. Hewitt et al.

BMC CANCER (2006)

Article Gastroenterology & Hepatology

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

MN Wente et al.

PANCREAS (2005)

Article Pathology

Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer

SE Dowen et al.

AMERICAN JOURNAL OF PATHOLOGY (2005)

Article Pathology

Application of mesothelin immunostaining in tumor diagnosis

NG Ordonez

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)